Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: Clin Cancer Res. 2019 Nov 15;26(4):862–869. doi: 10.1158/1078-0432.CCR-18-4067

Figure 4.

Figure 4.

Heterogeneity index* distributions of women in low, medium, and high heterogeneity phenotypes in the discovery (A) and validation (B) cohorts.

* defined as the statistical average of z-score normalized, heterogeneity standardized features in the final feature vector for each tumor in the discovery and validation cohorts.